Item 2.02. Results of Operations and Financial Condition.
The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
Attached hereto as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated April 30, 2026, announcing the financial results of Eli Lilly and Company for the quarter ended March 31, 2026.
Item 9.01. Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press Release of Eli Lilly and Company, datedApril 30, 2026.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).